TREATING FEVER AND PAIN in the time of COVID-19 Many people are asking doctors for information about whether it is safe to use NSAID drugs now. Examples of this drug class include ibuprofen (generic, Advil, Motrin), naproxen (generic, Aleve), diclofenac (generic, Voltaren, Arthrotec), celecoxib (Celebrex), meloxicam (Mobicox) and many others. Feeling an increase in your body temperature can … [Read more...]
Links to authoritative sites and medical journals regarding COVID-19
We are sharing below some links to authoritative sites and medical journals, regarding COVID-19, that we are checking regularly: For GENERAL INFORMATION: 1. BC CDC public information website: GENERAL INFORMATION: http://www.bccdc.ca/health-info/diseases-conditions/covid-19 A SCREENING TOOL To TRIAGE YOURSELF: https://covid19.thrive.health/ --> an easy self-assessment online … [Read more...]
BCCDC COVID-19 Clinical guidance
This information is for health care professionals and public health partners. BCCDC is monitoring an outbreak of novel coronavirus (COVID-19) and is working with provincial and federal partners on surveillance, diagnostic testing and infection control measures. … [Read more...]
[VIDEO] Pill splitting: Making the most of meds in a time of need
Randomized clinical trials are the only way to learn how we should treat COVID-19
“Hydroxychloroquine and azithromycin taken together have a real chance to be one of the biggest game changers in the history of medicine.” Tweet by President Donald Trump. There are very few “game changers” in the history of prescription drugs. During this global health emergency, demand for an effective treatment for COVID-19 is fervent. From the US President to his Twitter-feeding … [Read more...]
Malaria Drugs in COVID-19: Hope or Hype?
Clinical trials may soon provide answers. by Pippa Wysong, Contributing Writer, MedPage Today March 26, 2020 … [Read more...]
Response to the Coronavirus (COVID-19) Pandemic
Currently staff at the Therapeutics Initiative have been instructed to stay home and are able to work remotely. All in-person meetings have been cancelled but we are continuing our team’s work online and via teleconferences. All the members of UBC’s Therapeutics Initiative would like to thank our frontline clinical and health services colleagues (of all types), and other essential service … [Read more...]
New Publications from the TI PharmacoEpidemiology Group
We are highlighting 2 recent articles published by members of the PharmacoEpidemiology Group (PEG) of the Therapeutics Initiative: Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System … [Read more...]
New Publications from the TI PharmacoEpidemiology Group
We are highlighting 2 recent articles published by members of the PharmacoEpidemiology Group (PEG) of the Therapeutics Initiative: A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non‐depressed adults: a retrospective … [Read more...]
New Publications from the TI PharmacoEpidemiology Group
We are highlighting 4 recent articles published by members of the PharmacoEpidemiology Group (PEG) of the Therapeutics Initiative: Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study Comparison of cholinesterase … [Read more...]
- 1
- 2
- 3
- …
- 13
- Next Page »
